To determine the potential role of JMJD1A noncanonical ubiquitination in the sensitivity of PCa cells to PRAR inhibitors, we also performed MTT assays to evaluate the cell viability in response to the PARP inhibitor olaparib. This evidence concerns the gene KDM3A and posterior cortical atrophy.